Back
Monte Rosa Therapeutics Quote, Financials, Valuation and Earnings
Trump's IRS Hands Massive 'Victory Gift' To 401K Owners
Shield your IRA, 401(k) and pension savings from this coming anti-Trump backlash.
Buy
53
GLUE
Monte Rosa Therapeutics
Last Price:
8.55
Seasonality Move:
-8.98%
7 Day Trial
ALL ACCESS PASS
$
7
America's enemies are regrouping & it may sucker punch your savings
Click here to learn more.Monte Rosa Therapeutics Price Quote
$8.55
+0.19 (+2.27%)
(Updated: November 21, 2024 at 11:20 AM ET)
Monte Rosa Therapeutics Key Stats
Buy
53
Monte Rosa Therapeutics (GLUE)
is a Buy
Day range:
$8.05 - $8.62
52-week range:
$2.91 - $12.40
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
2.25%
Volume:
736.1K
Avg. volume:
4.1M
1-year change:
157.23%
Market cap:
$463.2M
Revenue:
$0
EPS:
$-1.83
How Much Does Monte Rosa Therapeutics Make?
Data Unavailable
Is Monte Rosa Therapeutics Growing As A Company?
Data Unavailable
Monte Rosa Therapeutics Stock Price Performance
-
Did Monte Rosa Therapeutics Stock Go Up Last Month?
Monte Rosa Therapeutics share price went up by 51.45% last month -
Did GLUE's Share Price Rise Over The Last Year?
GLUE share price rose by 157.23% over the past 1 year
What Is Monte Rosa Therapeutics 52-Week High & Low?
-
What Is Monte Rosa Therapeutics’s 52-Week High Share Price?
Monte Rosa Therapeutics has traded as high as $12.40 over the past 52 weeks -
What Is Monte Rosa Therapeutics’s 52-Week Low Share Price?
Monte Rosa Therapeutics has traded as low as $2.91 over the past 52 weeks
Monte Rosa Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Monte Rosa Therapeutics?
-
How Much Debt Does Monte Rosa Therapeutics Have?
Total long term debt quarterly is $0 -
How Much Cash Does Monte Rosa Therapeutics Have?
Cash and short term investments quarterly total is $242.2M -
What Is Monte Rosa Therapeutics’s Book Value Per Share?
Book value per share is 3.35
Is Monte Rosa Therapeutics Cash Flow Positive?
-
What Is GLUE Cash Flow From Operations?
Cash flow from operations (TTM) is -$57.3M -
What Is Monte Rosa Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $123.5M -
What Is Monte Rosa Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is $741K
Monte Rosa Therapeutics Return On Invested Capital
Data Unavailable
Monte Rosa Therapeutics Earnings Date & Stock Price
-
What Is Monte Rosa Therapeutics's Stock Price Today?
A single share of GLUE can be purchased today for 8.36 -
What Is Monte Rosa Therapeutics’s Stock Symbol?
Monte Rosa Therapeutics trades on the nasdaq under the ticker symbol: GLUE -
When Is Monte Rosa Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Monte Rosa Therapeutics is scheduled on March 14, 2025 -
When Is GLUE's next ex-dividend date?
Monte Rosa Therapeutics's next ex-dividend date is November 21, 2024 -
How To Buy Monte Rosa Therapeutics Stock?
You can buy Monte Rosa Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Monte Rosa Therapeutics Competitors
-
Who Are Monte Rosa Therapeutics's Competitors?
Below is a list of companies who compete with Monte Rosa Therapeutics or are related in some way:
Monte Rosa Therapeutics Dividend Yield
-
What Is GLUE Dividend Yield?
Monte Rosa Therapeutics’s dividend yield currently is 0% -
What Is Monte Rosa Therapeutics’s Payout Ratio?
Monte Rosa Therapeutics’s payout ratio is 0% -
When Did Monte Rosa Therapeutics Last Pay A Dividend?
The latest dividend pay date is November 21, 2024 -
What Is Monte Rosa Therapeutics’s Dividend Per Share?
Monte Rosa Therapeutics pays a dividend of $0.00 per share
Monte Rosa Therapeutics Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 38.42% |
| Revenue: | 0% | 183.67% |
Analyst Recommendations
| Buy Recommendations: | 6 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 16.43 |
| Upside from Last Price: | 96.51% |